Roxana Redis, Associate Science Director of Advanced Modalities, Charles River Laboratories, talks about the exciting field of RNA.

In the final quarter of the year, how can pharmaceutical teams make their final budget decisions count?

The former Baxter leader talks about the founding of Vantive, the challenges facing kidney patients, improving access to dialysis and more.

Ever wondered what one of the world’s top oncology leaders believes to be the next big thing in cancer care? Find out in our interview AstraZeneca’s Dr Sunil Verma.

What key compliance considerations should pharma companies keep in mind before releasing new research in the US market, and how can they avoid compliance pitfalls?

Video is a powerful tool because it extends the reach of a live event, but does a recording ever live up to the event itself? Enter 3D interactive video.

AI is becoming less of a buzzword for those in the pharma industry. For medical affairs teams, how will it transform the function’s future?

If you want to engage HCPs, you must deliver high-quality medical education. But are all companies taking advantage of interactive quizzes?

A US congress is the place to put your drug on the map, but is this landscape the home of great customer experience for HCPs?

In today’s fast-paced pharma industry, it is vital for companies to provide an excellent customer experience for healthcare professionals.

Hear from four pharma leaders on the benefits to employees and patients of workplaces that promote inclusivity for the LGBTQ+ community.

A 3D, interactive approach allows pharmaceutical companies to share the latest medical breakthroughs in a more dynamic and engaging way.

Dr Harmony Garges, talks to EMJ GOLD about her decision to join the pharmaceutical industry, treating children with HIV and her views on improving access to HIV treatment.

Learn about how 3D human technology offers pharmaceutical companies a fresh and exciting way to take medical education to new heights.

The journey from approval to patient can be convoluted. How can pharma teams communicate the latest advances to busy healthcare professionals?

Stefan Woxström, Senior Vice President Europe and Canada, AstraZeneca, talks about the need for future-proofing healthcare systems, incentivising innovation and reimbursement.

Finding a way to combat the negative effects of ageing could save healthcare systems millions. Learn whether ageing could be the next big pharma market to take the world by storm.

Robyn Widenmaier (GSK) and Tabetha Sundin (AstraZeneca) discuss whether bids to improve gender parity could be the ticket to change in women’s health.

A new generation of doctors is making their way into the workforce, but is the pharmaceutical industry ready to change its tactics to engage these younger HCPs?

The value of medical affairs is not up for debate, but are companies allocating enough time and resources to make it the strategic function it can be?

A deal ends months of wrangling between the UK government and the ABPI, but what will it mean for the industry and the UK’s bid to become a life sciences superpower?

With compliance and regulatory hoops to jump through, medical affairs teams can be reluctant to try new tactics. This roundtable uncovers their relationship with risk and asks what the future holds.

Peter Ahnesorg, Global Hematology Franchise Head, Roche, talks about his background in biochemistry, his hopes for the haematology space and his approach to leadership.

Discover the past and future of hematology. Uncover the challenges, advancements, and the industry’s commitment to patient well-being.

Read about the role the pharma industry can play in ensuring patients can access the right information about medical conditions and medicines.

Dr Andreas Konieczny, Vice President and Head of Medical Affairs Europe, ImmunoGen, talks to GOLD about moving from big pharma to biotech, his passion for oncology and lessons in leadership.

The Irish pharmaceutical sector is expanding. Read more about what is driving companies to channel investment into the Emerald Isle.

To mark World Heart Day 2023, how can the industry strike a balance between driving innovation and ensuring access to care for all?

How can companies best leverage their KOLs earlier in the product lifecycle, and how do KOLs themselves want to involved?

Medical affairs and sales teams have distinctly different roles, but aren’t they just two planets orbiting the same sun?

How can medical affairs achieve efficiencies by standardising and modernising its insight gathering processes?

As the UK PMCPA publishes its first social media guidance for pharmaceutical companies, what can they do to avoid traps when it comes to posting online?

The pharmaceutical industry is being urged to take action to bridge the access gap for women with gynaecological cancers, but what steps are needed to change the game?

Karen Pinachyan, Head of Medical Affairs for Europe, CSL Behring, talks to Isabel O’Brien about the power of personalised medicine, overhauling healthcare and why it is key to know your own mind

The Cannes Lions International Festival of Creativity is finished for another year, but how did the pharmaceutical industry perform?

This week (14-16 May) is National Women’s Health Week in the US. Read what the industry can do to close the gender health gap.

Lance Hill, CEO of Within3, talks to GOLD about the challenge of creating a market for their product and his personal and professional measures of success.

Marcel Gehrung, CEO and Co-Founder, Cyted, talks to Jade Williams about the greatest challenges facing his company.

GOLD talks to Stuart Peltz, CEO, PTC Therapeutics, about his company’s journey from a single lab to a multinational corporation.

Medical affairs must have its finger on the pulse of customer and patient preferences. Social listening is a key way for teams to keep up.

Sabine Hutchison, CEO, Seuss+, and Operating Board President, EMEA, The Healthcare Businesswomen’s Association, discusses the legislation, challenges and hopes for closing the pay gap in life sciences.

Pharma leader Emma Chaffin talks about leaving pharmacy for the pharma and a key challenge facing her function.

Synthetic data can streamline clinical trials and enable ideas to be tested without draining R&D budgets. Read more about pros and cons of this approach.

Explore the benefits of using agencies in pharma marketing and some of the reasons why creativity needs to be brought to the foreground.

Pharma is a popular destination for women entering the workforce, but how can the lack of representation at senior levels be addressed?

For pharma, building an ERG can be essential for inclusivity. Find out how to create a great one with these top tips.

Christi Shaw, former CEO, Kite Pharma, shares her thoughts on improving access to cell therapies and her motivations for working in oncology

Exploring the current state of the US pharmaceutical market, this article investigates the balance between innovation and access to care in the country.

Roche’s Davidek Herron offers his thoughts on the state of diversity, equity and inclusion in the pharma industry.

Despite continued advances in personalised medicine, there is still more to be done to encourage policy makers and payers to back these life-changing initiatives.

In 2021, the UK was named the sixth biggest pharmaceutical market, but it’s facing challenges to further growth. Read to find out more.

The future is brimming with possibilities for AI in healthcare, but eliminating bias is imperative, so where should pharma start?

AI holds buckets of potential for medical affairs teams, but it must be adopted considerately and correctly to meet their needs.

Pharma’s approach to customer experience could be improved with humanisation of digital touchpoints.

Novo Nordisk’s new obesity drug could be set to transform obesity care, but there’s much more that pharma can do to help.

GSK’s Judy Stewart discusses her ambition to work in pharmaceuticals and make a difference to public health, the vast GSK vaccine pipeline, leadership and the importance of work-life balance.